Loading...
XSHE300633
Market cap1.61bUSD
Jan 15, Last price  
27.49CNY
1D
-2.38%
1Q
-9.75%
IPO
232.00%
Name

SonoScape Medical Corp

Chart & Performance

D1W1MN
XSHE:300633 chart
P/E
26.05
P/S
5.58
EPS
1.06
Div Yield, %
0.00%
Shrs. gr., 5y
1.54%
Rev. gr., 5y
11.56%
Revenues
2.12b
+20.29%
484,247,538592,242,346639,724,282685,826,920719,356,862989,069,6631,226,848,9651,253,853,5751,163,081,8691,444,597,6281,762,648,9812,120,251,604
Net income
454m
+22.88%
129,941,41470,649,079131,752,489105,871,308130,427,136190,023,097252,623,779101,536,9450247,244,612369,807,923454,437,474
CFO
494m
+4.36%
15,488,30089,944,601113,548,68156,285,693137,377,685136,205,027233,647,896190,393,067271,131,439302,989,915473,255,552493,877,095
Dividend
May 29, 20240.32 CNY/sh
Earnings
May 09, 2025

Profile

SonoScape Medical Corp. develops and manufactures medical equipment in China and internationally. The company offers ultrasound diagnostic systems, such as trolley color Doppler, portable color Doppler, B/W ultrasound, and veterinary ultrasound equipment; and endoscopy equipment, such as image processors, light sources, and gastroenterology products. It also provides technical and spare parts support, training, upgradation, and field services. SonoScape Medical Corp. was founded in 2002 and is based in Shenzhen, China.
URL
https://www.sonoscape.com/
IPO date
Apr 06, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,120,252
20.29%
1,762,649
22.02%
Cost of revenue
1,586,599
1,359,671
Unusual Expense (Income)
NOPBT
533,653
402,978
NOPBT Margin
25.17%
22.86%
Operating Taxes
19,394
12,131
Tax Rate
3.63%
3.01%
NOPAT
514,259
390,848
Net income
454,437
22.88%
369,808
49.57%
Dividends
(53,483)
Dividend yield
0.23%
Proceeds from repurchase of equity
(59,992)
(25,370)
BB yield
0.29%
0.11%
Debt
Debt current
23,628
191,800
Long-term debt
68,015
54,183
Deferred revenue
22,831
26,908
Other long-term liabilities
2
Net debt
(1,691,181)
(1,510,677)
Cash flow
Cash from operating activities
493,877
473,256
CAPEX
(176,987)
Cash from investing activities
186,170
Cash from financing activities
(275,522)
3,781
FCF
295,670
282,078
Balance
Cash
1,826,011
1,756,659
Long term investments
(43,187)
Excess cash
1,676,811
1,668,526
Stockholders' equity
1,859,351
1,808,483
Invested Capital
1,549,609
1,290,206
ROIC
36.22%
32.36%
ROCE
16.54%
13.62%
EV
Common stock shares outstanding
432,798
427,862
Price
47.20
-13.92%
54.83
71.72%
Market cap
20,428,046
-12.92%
23,459,660
83.68%
EV
18,736,866
21,948,984
EBITDA
599,684
456,345
EV/EBITDA
31.24
48.10
Interest
8,825
3,705
Interest/NOPBT
1.65%
0.92%